Danaher Cost of Goods Sold 2012-2026 | DHR
Danaher annual/quarterly cost of goods sold history and growth rate from 2012 to 2026. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- Danaher cost of goods sold for the quarter ending March 31, 2026 was $2.360B, a 5.83% increase year-over-year.
- Danaher cost of goods sold for the twelve months ending March 31, 2026 was $10.175B, a 6.1% increase year-over-year.
- Danaher annual cost of goods sold for 2025 was $10.045B, a 3.89% increase from 2024.
- Danaher annual cost of goods sold for 2024 was $9.669B, a 1.9% decline from 2023.
- Danaher annual cost of goods sold for 2023 was $9.856B, a 5.73% decline from 2022.
|
Danaher Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2025 | $10,045 |
| 2024 | $9,669 |
| 2023 | $9,856 |
| 2022 | $10,455 |
| 2021 | $9,563 |
| 2020 | $9,809 |
| 2019 | $7,927 |
| 2018 | $7,544 |
| 2017 | $6,948 |
| 2016 | $7,548 |
| 2015 | $6,663 |
| 2014 | $6,017 |
| 2013 | $8,941 |
| 2012 | $8,846 |
| 2011 | $7,914 |
|
Danaher Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2026-03-31 | $2,360 |
| 2025-12-31 | $2,872 |
| 2025-09-30 | $2,530 |
| 2025-06-30 | $2,413 |
| 2025-03-31 | $2,230 |
| 2024-12-31 | $2,648 |
| 2024-09-30 | $2,397 |
| 2024-06-30 | $2,315 |
| 2024-03-31 | $2,309 |
| 2023-12-31 | $2,626 |
| 2023-09-30 | $2,349 |
| 2023-06-30 | $2,594 |
| 2023-03-31 | $2,287 |
| 2022-12-31 | $1,363 |
| 2022-09-30 | $3,079 |
| 2022-06-30 | $3,030 |
| 2022-03-31 | $2,983 |
| 2021-12-31 | $1,267 |
| 2021-09-30 | $2,870 |
| 2021-06-30 | $2,821 |
| 2021-03-31 | $2,605 |
| 2020-12-31 | $2,806 |
| 2020-09-30 | $2,658 |
| 2020-06-30 | $2,445 |
| 2020-03-31 | $1,900 |
| 2019-12-31 | $2,164 |
| 2019-09-30 | $1,937 |
| 2019-06-30 | $1,961 |
| 2019-03-31 | $1,865 |
| 2018-12-31 | $1,166 |
| 2018-09-30 | $2,163 |
| 2018-06-30 | $2,164 |
| 2018-03-31 | $2,052 |
| 2017-12-31 | $1,057 |
| 2017-09-30 | $1,991 |
| 2017-06-30 | $2,028 |
| 2017-03-31 | $1,871 |
| 2016-12-31 | $2,084 |
| 2016-09-30 | $1,846 |
| 2016-06-30 | $1,861 |
| 2016-03-31 | $1,757 |
| 2015-12-31 | $501 |
| 2015-09-30 | $1,619 |
| 2015-06-30 | $2,316 |
| 2015-03-31 | $2,227 |
| 2014-12-31 | $2,614 |
| 2014-09-30 | $2,255 |
| 2014-06-30 | $2,343 |
| 2014-03-31 | $2,210 |
| 2013-12-31 | $2,555 |
| 2013-09-30 | $2,244 |
| 2013-06-30 | $2,242 |
| 2013-03-31 | $2,119 |
| 2012-12-31 | $2,430 |
| 2012-09-30 | $2,138 |
| 2012-06-30 | $2,198 |
| 2012-03-31 | $2,081 |
| 2011-12-31 | $2,390 |
| 2011-09-30 | $2,263 |
| 2011-06-30 | $1,718 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $134.187B | $24.568B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Cencora (COR) | United States | $62.409B | 19.63 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| Revvity (RVTY) | United States | $10.039B | 17.71 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |